Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2024)
Top medical stocks in 2024 ranked by overall Due Diligence Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

Industry: Medical Instruments & Sup...

Overview Due Diligence Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
HOLX	HOLOGIC INC	United States	$17.10B	226,941,217	86.88%	13.12%	Net Selling	Net Selling
RMD	RESMED INC	United States	$35.44B	146,795,746	58.87%	4.25%	Net Selling	Net Selling
UTMD	UTAH MEDICAL PRODUCTS INC	United States	$216.52M	3,391,620	63.95%	36.05%	Net Selling
BDX	BECTON DICKINSON & CO	United States	$63.61B	289,122,120	87.26%	0.65%	Net Selling	Net Selling
LMAT	LEMAITRE VASCULAR INC	United States	$2.27B	22,484,021	75.57%	24.43%	Net Selling	Net Buying
ISRG	INTUITIVE SURGICAL INC	United States	$196.04B	356,179,445	83.33%	0.80%	Net Buying	Net Selling
MMSI	MERIT MEDICAL SYSTEMS INC	United States	$6.08B	58,279,409	95.00%	5.00%	Net Selling	Net Buying
ATR	APTARGROUP INC	United States	$11.39B	66,543,252	89.01%	3.65%	Net Selling	Net Selling
ALC	ALCON INC	United States	$42.91B	494,600,000	49.48%	0.00%
WST	WEST PHARMACEUTICAL SERVICES INC	United States	$23.36B	72,422,349	93.44%	3.71%	Net Buying	Net Selling
HAE	HAEMONETICS CORP	United States	$4.08B	50,223,887	97.51%	2.49%	Net Selling	Net Selling
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	China	$11.25M	23,940,000	10.26%	0.00%
NYXH	NYXOAH SA	Belgium	$263.08M	34,389,015	11.94%	0.00%
STAA	STAAR SURGICAL CO	United States	$1.25B	49,275,875	61.51%	38.49%	Net Buying
TFX	TELEFLEX INC	United States	$8.58B	46,443,734	95.94%	2.76%	Net Selling
ATRC	ATRICURE INC	United States	$1.67B	48,753,251	75.95%	24.05%	Net Selling
OSUR	ORASURE TECHNOLOGIES INC	United States	$291.66M	74,594,154	89.03%	8.03%	Net Selling
COO	COOPER COMPANIES INC	United States	$19.70B	199,582,626	94.95%	0.98%	Net Selling	Net Selling
WRBY	WARBY PARKER INC	United States	$2.86B	120,336,921	51.78%	48.22%	Net Selling	Net Selling
INFU	INFUSYSTEM HOLDINGS INC	United States	$189.88M	21,263,597	26.61%	73.39%	Net Selling	Net Selling
XRAY	DENTSPLY SIRONA INC	United States	$3.79B	198,779,568	97.75%	2.25%	Net Selling	Net Selling
NEPH	NEPHROS INC	United States	$16.99M	10,544,225	5.55%	94.45%	Net Buying
EMBC	EMBECTA CORP	United States	$1.11B	57,701,830	94.65%	2.01%	Net Selling	Net Selling
LUCY	INNOVATIVE EYEWEAR INC	United States	$16.24M	2,442,248	1.14%	98.86%	Net Buying	Net Buying
HBIO	HARVARD BIOSCIENCE INC	United States	$98.57M	43,616,621	49.88%	50.12%	Net Selling
POAI	PREDICTIVE ONCOLOGY INC	United States	$5.35M	6,666,993	0.09%	99.91%
SMTI	SANARA MEDTECH INC	United States	$320.28M	8,741,161	0.63%	99.37%	Net Selling
PDEX	PRO DEX INC	United States	$175.25M	3,259,338	5.42%	94.58%	Net Selling	Net Buying
EKSO	EKSO BIONICS HOLDINGS INC	United States	$14.91M	21,998,369	17.00%	83.00%
ZJYL	JIN MEDICAL INTERNATIONAL LTD	China	$115.52M	160,000,000	1.11%	0.00%
PLSE	PULSE BIOSCIENCES INC	United States	$1.21B	61,516,677	9.12%	80.58%	Net Buying	Net Buying
BLFS	BIOLIFE SOLUTIONS INC	United States	$1.22B	46,387,214	58.91%	41.09%	Net Selling	Net Selling
FEMY	FEMASYS INC	United States	$25.65M	22,898,468	7.10%	7.77%
BAX	BAXTER INTERNATIONAL INC	United States	$16.24B	510,587,581	84.90%	15.10%	Net Selling	Net Selling
KRMD	KORU MEDICAL SYSTEMS INC	United States	$174.18M	45,837,304	27.87%	47.79%	Net Buying	Net Buying
NXGL	NEXGEL INC	United States	$23.70M	6,790,777	3.37%	29.93%	Net Buying	Net Buying
STVN	STEVANATO GROUP SPA	Italy	$6.20B	302,842,536	17.87%	0.00%
BLCO	BAUSCH & LOMB CORP	Canada	$7.07B	352,164,025	10.73%	88.84%	Net Buying	Net Buying
AVGR	AVINGER INC	United States	$2.61M	3,196,791	4.40%	79.64%	Net Selling
BNGO	BIONANO GENOMICS INC	United States	$23.87M	101,993,225	5.35%	25.44%	Net Selling	Net Selling
AZTA	AZENTA INC	United States	$2.51B	55,003,056	69.49%	30.51%	Net Buying	Net Buying
POCI	PRECISION OPTICS CORPORATION INC	United States	$32.32M	6,350,170	12.69%	87.31%	Net Selling	Net Selling
RVP	RETRACTABLE TECHNOLOGIES INC	United States	$18.56M	29,937,159	6.62%	93.38%	Net Buying	Net Buying
RGEN	REPLIGEN CORP	United States	$8.36B	56,026,725	72.44%	27.56%	Net Selling	Net Buying
MLSS	MILESTONE SCIENTIFIC INC	United States	$68.93M	77,892,083	5.45%	57.43%	Net Buying	Net Selling
ICUI	ICU MEDICAL INC	United States	$3.81B	24,484,266	70.83%	29.17%	Net Selling	Net Selling
OMIC	SINGULAR GENOMICS SYSTEMS INC	United States	$50.29M	2,511,783	5.58%	94.42%	Net Buying	Net Buying
ZTEK	ZENTEK LTD	Canada	$113.43M	104,064,815	1.41%	0.00%
MBOT	MICROBOT MEDICAL INC	United States	$16.56M	16,932,341	3.18%	96.82%
ANGO	ANGIODYNAMICS INC	United States	$284.44M	40,634,249	77.57%	22.43%	Net Selling	Net Buying
NVST	ENVISTA HOLDINGS CORP	United States	$3.42B	172,096,816	64.30%	35.70%	Net Selling	Net Selling
STSS	SHARPS TECHNOLOGY INC	United States	$3.61M	1,797,795	18.06%	81.94%	Net Buying	Net Buying
AKYA	AKOYA BIOSCIENCES INC	United States	$105.07M	49,563,386	24.40%	53.19%	Net Selling
STXS	STEREOTAXIS INC	United States	$187.25M	84,729,507	27.25%	72.75%	Net Buying
GCTK	GLUCOTRACK INC	United States	$1.47M	5,772,026	0.95%	75.97%	Net Buying

Medical Stocks FAQ

What are the best medical stocks to buy right now in Dec 2024?

According to Due Diligence Score, the 3 best medical stocks to buy right now are:

1. Hologic (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) is the top medical stock with a Due Diligence Score of 55, which is 27 points higher than the medical industry average of 28. It passed 17 out of 33 due diligence checks and has strong fundamentals. Hologic has seen its stock return 9.01% over the past year, underperforming other medical stocks by -9 percentage points.

Hologic has an average 1 year price target of $89.40, an upside of 18.66% from Hologic's current stock price of $75.34.

Hologic stock has a consensus Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Hologic, 20% have issued a Strong Buy rating, 40% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Resmed (NYSE:RMD)

Resmed (NYSE:RMD) is the second best medical stock with a Due Diligence Score of 54, which is 26 points higher than the medical industry average of 28. It passed 20 out of 38 due diligence checks and has strong fundamentals. Resmed has seen its stock return 47.2% over the past year, overperforming other medical stocks by 29 percentage points.

Resmed has an average 1 year price target of $244.50, an upside of 1.28% from Resmed's current stock price of $241.41.

Resmed stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Resmed, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 33.33% have issued a hold, while 16.67% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Lemaitre Vascular (NASDAQ:LMAT)

Lemaitre Vascular (NASDAQ:LMAT) is the third best medical stock with a Due Diligence Score of 48, which is 20 points higher than the medical industry average of 28. It passed 18 out of 38 due diligence checks and has strong fundamentals. Lemaitre Vascular has seen its stock return 86.43% over the past year, overperforming other medical stocks by 69 percentage points.

Lemaitre Vascular has an average 1 year price target of $95.50, a downside of -5.56% from Lemaitre Vascular's current stock price of $101.12.

Lemaitre Vascular stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Lemaitre Vascular, 0% have issued a Strong Buy rating, 75% have issued a Buy, 25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 9 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 3.25%, which is 2 percentage points higher than the medical industry average of 1.36%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -30% indicates that its dividend yield might not be sustainable for the long-term.

2. Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) has an annual dividend yield of 2.36%, which is 1 percentage points higher than the medical industry average of 1.36%. Baxter International's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of 552.4% indicates that its dividend yield might not be sustainable for the long-term.

3. Utah Medical Products (NASDAQ:UTMD)

Utah Medical Products (NASDAQ:UTMD) has an annual dividend yield of 1.88%, which is 1 percentage points higher than the medical industry average of 1.36%. Utah Medical Products's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Utah Medical Products's dividend has shown consistent growth over the last 10 years.

Utah Medical Products's dividend payout ratio of 28.1% indicates that its dividend yield is sustainable for the long-term.

Why are medical stocks up?

Medical stocks were up 0.35% in the last day, and down -2.03% over the last week.

We couldn't find a catalyst for why medical stocks are up.

What are the most undervalued medical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

1. Utah Medical Products (NASDAQ:UTMD)

Utah Medical Products (NASDAQ:UTMD) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Utah Medical Products has a valuation score of 71, which is 54 points higher than the medical industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Utah Medical Products's stock has dropped -21.73% in the past year. It has underperformed other stocks in the medical industry by -40 percentage points.

2. Hologic (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Hologic has a valuation score of 71, which is 54 points higher than the medical industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Hologic's stock has gained 9.01% in the past year. It has underperformed other stocks in the medical industry by -9 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Embecta has a valuation score of 57, which is 40 points higher than the medical industry average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has gained 9.13% in the past year. It has underperformed other stocks in the medical industry by -9 percentage points.

Are medical stocks a good buy now?

45.95% of medical stocks rated by analysts are a buy right now. On average, analysts expect medical stocks to rise by 14.39% over the next year.

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 38.62x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.